Biolexis

Biolexis is an emerging biotechnology and vaccine company with the capability to develop and commercialize products for the global market. The company, a wholly-owned subsidiary of Stelis, focuses on building and licensing a portfolio of advanced biosimilars, peptides, and vaccines.